A novel prognostic model for predicting the risk of first variceal hemorrhage in patients with HBV-related cirrhosis
Frontiers in Cellular and Infection Microbiology · 2023
DOI: 10.3389/fcimb.2023.1062172 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2023. Verfasst von Qun Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Esophageal and Gastric Varices, Varicose Veins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Variceal hemorrhage (VH) is a life-threatening complication of cirrhosis. An accurate VH risk evaluation is critical to determine appropriate prevention strategies. We aimed to develop an individualized prediction model to predict the risk of first VH in hepatitis B virus (HBV)-related cirrhotic patients.
Methods
A nomogram was developed based on a retrospective analysis of 527 consecutive HBV-related cirrhotic patients with gastroesophageal varices (GEVs). The nomogram evaluation was performed using the area under the receiver operating characteristic curve (AUC), concordance index (C-index), calibration plot, and decision curve analysis (DCA). The results were verified using an external cohort (n = 187).
Results
We developed a nomogram based on clinical and endoscopic features, including the size of varices, red wale marks, ascites, spleen thickness, γ‐glutamyltransferase, and hematocrit. The C-index of the nomogram in the derivation and validation cohort was 0.806 and 0.820, respectively, and the calibration plot fitted well. Compared with those of the North Italian Endoscopic Club (NIEC) and revised NIEC indexes, the AUC (derivation cohort: 0.822 vs. 0.653 vs. 0.713; validation cohort: 0.846 vs. 0.685 vs. 0.747) and DCA curves of this nomogram were better. Further, based on the risk scores, patients were classified into low-, medium-, and high-risk groups, and significant differences were noted in VH incidence among the three risk groups ( P < 0.001 for each cohort).
Conclusions
An effective individualized nomogram to predict the risk of first VH in HBV-related GEV patients was established, which can assist clinicians in developing more appropriate prevention strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
- Institute of Liver Diseases, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhang, Q., Niu, S., Yang, L., Zhu, B., Shi, K., Zhang, X., Zhang, Y., Bi, Y., Mu, Y., & Wang, X. (2023). A novel prognostic model for predicting the risk of first variceal hemorrhage in patients with HBV-related cirrhosis. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2023.1062172
Vancouver
Zhang Q, Niu S, Yang L, Zhu B, Shi K, Zhang X, et al. A novel prognostic model for predicting the risk of first variceal hemorrhage in patients with HBV-related cirrhosis. Frontiers in Cellular and Infection Microbiology. 2023. doi:10.3389/fcimb.2023.1062172
BibTeX
@article{Zhang2023,
author = {Zhang, Qun and Niu, Shuaishuai and Yang, Li and Zhu, Bingbing and Shi, Ke and Zhang, Xiaohua and Zhang, Yi and Bi, Yufei and Mu, Yongping and Wang, Xianbo},
title = {A novel prognostic model for predicting the risk of first variceal hemorrhage in patients with HBV-related cirrhosis},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2023},
doi = {10.3389/fcimb.2023.1062172}
}
EUVIMED